All lobbying filings

BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for ABBVIE · Biopharmaceutical company

Filing 3rd Quarter - Report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 16, 2025

Income

$80,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

Executive Office of the President (EOP)
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Health Issues

Issues related to patient access, pharmaceutical manufacturing, Patent reform, and drug pricing both domestic and international Issues related to Medicare drug pricing and reimbursement DTC Advertising

Tariff (miscellaneous tariff bills)

Reciprocal tariffs

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.